Healthcare of Ontario Pension Plan Trust Fund boosted its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 198.6% in the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 9,229,000 shares of the exchange traded fund’s stock after buying an additional 6,138,000 shares during the quarter. SPDR S&P Biotech ETF accounts for approximately 2.2% of Healthcare of Ontario Pension Plan Trust Fund’s holdings, making the stock its 8th biggest position. Healthcare of Ontario Pension Plan Trust Fund owned approximately 0.12% of SPDR S&P Biotech ETF worth $911,825,000 as of its most recent SEC filing.
Several other hedge funds have also recently made changes to their positions in the stock. Tidemark LLC increased its holdings in SPDR S&P Biotech ETF by 101.5% during the third quarter. Tidemark LLC now owns 395 shares of the exchange traded fund’s stock valued at $39,000 after buying an additional 199 shares during the last quarter. ORG Partners LLC bought a new stake in SPDR S&P Biotech ETF during the second quarter valued at about $40,000. Quintet Private Bank Europe S.A. bought a new stake in SPDR S&P Biotech ETF during the third quarter valued at about $40,000. ORG Wealth Partners LLC bought a new position in shares of SPDR S&P Biotech ETF in the third quarter worth about $44,000. Finally, Howe & Rusling Inc. purchased a new position in shares of SPDR S&P Biotech ETF during the 3rd quarter valued at about $49,000.
SPDR S&P Biotech ETF Trading Up 1.2 %
SPDR S&P Biotech ETF stock opened at $98.80 on Wednesday. SPDR S&P Biotech ETF has a 12-month low of $71.99 and a 12-month high of $105.47. The firm has a market capitalization of $7.53 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11. The firm has a 50 day moving average of $98.37 and a 200 day moving average of $96.38.
SPDR S&P Biotech ETF Company Profile
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.
See Also
- Five stocks we like better than SPDR S&P Biotech ETF
- What Are Trending Stocks? Trending Stocks Explained
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- 3 Stocks to Consider Buying in October
- 2 Generic Drug Stocks Ready to Surge in 2025
- Stock Sentiment Analysis: How it Works
- 3 Small-Cap Stocks That Are Ready to Rocket Higher
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.